Virtual Library

Start Your Search

Alma Cani



Author of

  • +

    EP1.15 - Thymoma/Other Thoracic Malignancies (ID 205)

    • Event: WCLC 2019
    • Type: E-Poster Viewing in the Exhibit Hall
    • Track: Thymoma/Other Thoracic Malignancies
    • Presentations: 1
    • Now Available
    • Moderators:
    • Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
    • +

      EP1.15-26 - Cardio Mediastinal Tumors - Diagnosis and Treatment in Two of Our Cases (Now Available) (ID 149)

      08:00 - 18:00  |  Author(s): Alma Cani

      • Abstract
      • Slides

      Background

      Malignant cardiac tumors are very rare.Although they are clinically diagnosed and diagnoses very quickly ,but in some cases it is very difficult to diagnose or are diagnosed in the late stages.

      Objective: To analyze our rarly two cases for diagnosis and treatment in delayed diagnoses for cardiac primary tumor invadation in mediastinum and pericardium tumor wih myocardial and mediastinal invasion in the other case. The diagnosis is based on the clinical history, echocardiography in two cases, and, sometimes, computerized tomography and magnetic resonance imaging,FNAB and mediastinotomy .

      Method

      In two cases the diagnosis is based on the clinical history, echocardiography in two cases, and, computerized tomography and magnetic resonance imaging,FNAB and mediastinotomy .

      Result

      Patient A. 66 years old ,male patient the diagnosis was established with trans-thoracic biopsies of myosarcoma-derived mass, treated by oncologist and cardiologists.While patient B is a 45 year old female with a pericardiac tumor,with huge pericardial effusion and effusion in the sinister pleural cavity. Liquid cytology with malignant cells. Was performed left mediastinotomy , pericardiotomy ,biopsy of intrapericardial mass, pericardial window and drainage pleural sinister . Biopsy results in pericardial sarcomatous mesothelioma with myocardial and mediastinal invasion. Macroscopically hemorrhagic effusion in pericardial and left pleural cavities. Very large tumor and quite intrapericardial hemorrhagic disease.

      Conclusion

      Malignant cardiac tumors are very rare and early stage diagnosis and adequate treatment is difficult.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • +

    EP1.17 - Treatment of Early Stage/Localized Disease (ID 207)

    • Event: WCLC 2019
    • Type: E-Poster Viewing in the Exhibit Hall
    • Track: Treatment of Early Stage/Localized Disease
    • Presentations: 2
    • Now Available
    • Moderators:
    • Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
    • +

      EP1.17-26 - Spontaneous Right Contralateral Total Pneumothorax in Bullous Lung After Left Pneumonectomy for Lung Cancer (Now Available) (ID 148)

      08:00 - 18:00  |  Author(s): Alma Cani

      • Abstract
      • Slides

      Background

      Introduction: The spontaneous contralateral pneumothorax after pneumonectomy is very rare and with a high death rate.

      Objective: To introduce a patient with spontaneous total pneumothorax in the right hemithorachal post-pneumonectomy with dg.:cancer bronchial. The treatment alternatives are controversial.

      Method

      Involved a 52-year-old man with non-small-cell lung cancer (NSCLC) who underwent left pneumonectomy after induction chemoradiotherapy on 2015.One year after surgery 2016 he had total right pneumothorax was treated by pleural drainage. Two(2) years after surgery 2018 , he had recureent pneumothorax and was treated with chest tube drainage and pleurodesis with autolog blood. He was discharged and no pneumothorax recurrence occurred for one year.

      Result

      After one year he had total pneumothorax right side and severe respiratory insuficience .He came to our hospital 3 hour after right Pneumothorax was started.O2SAT 60 %.Imediatly was treated with right chest tube drainage and airlack was stoped but for safety reason was discharged with Heimlich valvul after pleurodesis with povidion jod(BETADINE) .Heimlich valvul was get out after 10 days.The clinical status of patient is good.

      Conclusion

      Although management of pneumothorax after pneumonectomy is challenging, surgical intervention may be useful and necessary especially when there is high risk of recurrent pneumothorax.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

    • +

      EP1.17-31 - 30 Days Major Morbidity and Mortality After Lung Cancer Surgery. Outcomes of Five Years in a Single Center Experience (Now Available) (ID 405)

      08:00 - 18:00  |  Author(s): Alma Cani

      • Abstract
      • Slides

      Background

      Lung cancer is the leading cause of cancer-related death in the world. Surgery offers the best potential cure, but as in any surgery there are some complications that will be minimized with the improvement of surgical practice and treatment protocols. The aim of this study was to clarify the level of service we are providing in order to improve it and to add more information in the global database on the Thoracic Morbidity and Mortality classification system for patients undergoing lung resection.

      Method

      This is a retrospective study that included all patients who underwent lung resection in our department from January 2011 to January 2015. The parameters examined were postoperative mortality thirty days and postoperative complications. Both patients were evaluated prior to surgery according to the Karnofsky score and the intervention was performed by postero-lateral thoracotomy.

      Result

      There were 216 patients who were operated on for lung cancer in which 37 (17%) of them underwent pneumonectomy meanwhile the rest lobectomies, bilobectomies and anatomical segmentectomies. The average age was 62.4 years (± 12SD). 12% of patients were women and 88% males. 79% were smokers and 21% non-smokers. According to TNM classification, 10.2% of cases were in the first stage, 44% in the second stage, 21.3% in the third stage and 5.6% in the fourth stage. 40.4% of cases had another illness (cardiovascular disease 24.2%, COPD 11.8%, diabetes mellitus 3.7% and other diseases 0.6%).

      17% of patients had complications 30 days after surgery and only 2.3% died. As for pneumonectomy, the complication rate was 24% and the mortality rate was 8%. The main complications that have been observed were 19 cases of empyema, 4 cases of broncho-pleural fistula, 4 cases of pneumonia, 3 cases of prolonged air loss, 3 cases of heart attack and in 4 cases different complications were observed. 2 of mortality occurred due to a heart attack, in 2 cases occurred due to severe pneumonia and in one case a vascular accident occurred during the operation. Hospital stay was 8.5±3 days.

      Conclusion

      In our specialty, the complication rate following a surgical operation is a parameter very often used to check the quality level provided by health professionals. Our results show average mortality and morbidity after lung cancer surgery. However, patients with reduced lung capacity and undergoing pneumonectomy should be treated with the utmost care, since they run a considerable risk of major complications or death during the first 30 days after surgery.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.